Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

121 trials with published results (16%)

Research Maturity

392 completed trials (52% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

6.4%

49 terminated out of 760 trials

Success Rate

88.9%

+2.4% vs benchmark

Late-Stage Pipeline

10%

74 trials in Phase 3/4

Results Transparency

31%

121 of 392 completed with results

Key Signals

121 with results89% success49 terminated

Data Visualizations

Phase Distribution

533Total
Not Applicable (359)
Early P 1 (12)
P 1 (39)
P 2 (49)
P 3 (21)
P 4 (53)

Trial Status

Completed392
Unknown149
Recruiting84
Terminated49
Not Yet Recruiting31
Active Not Recruiting26

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 392 completed trials

Clinical Trials (760)

Showing 20 of 20 trials
NCT05313165Not ApplicableRecruiting

PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

NCT06399809Phase 2RecruitingPrimary

Fisetin to Reduce Senescence and Mobility Impairment in PAD

NCT06032065Phase 3RecruitingPrimary

SMART Exercise for PAD

NCT06491810CompletedPrimary

Oxygen Saturation in the Leg Musculature Affected by Peripheral Arterial Disease During Exercise on an Arm Ergometer

NCT06828172Not ApplicableEnrolling By InvitationPrimary

Local or Systemic Effects: Mechanisms Related to Arm Crank Exercise - Comparison Between Individuals With and Without PAD

NCT07076082Phase 4RecruitingPrimary

Vascular Trial Associated Registry Pilot

NCT07497360RecruitingPrimary

Tele-assessment and Face-to-face Assessment of the 30-second Sit-stand Test in Peripheral Artery Disease

NCT05009862Phase 4CompletedPrimary

The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease

NCT04584632Not ApplicableRecruitingPrimary

The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery

NCT05755412TerminatedPrimary

Shockwave ®S4 Catheter IVL to Treat Infrapopliteal Calcified Stenoses and/or Occlusions in CLTI Patients (LEGACY)

NCT04801004CompletedPrimary

A Real-world Study to Evaluate the Primary Patency and Freedom From TLR of Endovascular Treatment in TOSAKA III In-stent Restenosis of Lower Extremity Femoropopliteal Artery.

NCT05880641Recruiting

Use of Shockwave M5+/L6 IVL Catheter (Intravascular Lithotripsy) in Hostile and Calcified Iliac Access

NCT04774159Phase 3RecruitingPrimary

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

NCT04054440Completed

Outpatient Office Based Endovascular Procedures

NCT06277362RecruitingPrimary

Peripheral Extreme Revascularization in "No-option" Patiens With Chronic Limb Threatening Ischemia

NCT07223593Phase 3RecruitingPrimary

Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

NCT04971772Active Not RecruitingPrimary

SIGNATURE Study : DCB (Legflow) vs POBA in Fempop Arteries

NCT07353905Not ApplicableRecruitingPrimary

Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries

NCT07472049RecruitingPrimary

Symptomatic and Systemic Atherosclerotic Plaque Activity in Patients With Peripheral Arterial Disease Using Novel Imaging

NCT07472439Not ApplicableNot Yet RecruitingPrimary

Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone in Europe

Scroll to load more

Research Network

Activity Timeline